Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucose-lowering drugs as adjuncts to insulin in Chinese adults with type 1 diabetes
ChiCTR2500110682Phase 4Not yet recruiting
- Sponsor
- Shanghai General Hospital
- Start
- Oct 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of human insulin in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Shanghai General Hospital. Primary endpoints: HbA1c, Absolute insulin dose and 1 more. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
human insulin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on ChiCTR2500110682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500110682.